Tag: infliximab

TNF Inhibitors and TB Reactivation: Screening and Monitoring Guidelines

TNF inhibitors like adalimumab and infliximab are powerful for autoimmune diseases but carry a significant risk of reactivating latent tuberculosis. Proper screening, treatment of latent TB, and ongoing monitoring are essential to prevent life-threatening complications.

  • Dec, 16 2025
  • 13